Nabumetone Catalog No.:M8907-2 Disruption of Autophagic Degradation with

Disruption of Autophagic Degradation with ROC-325 Antagonizes Renal Cell Carcinoma Pathogenesis

Vemurafenib

and the cytotoxicity by SKI-II was almost reversed by the general caspase inhibitor z-VAD-fmk

N-dimethyl-2

Nabumetone Catalog No.:M8907-2 Disruption of Autophagic Degradation withNabumetone is a non steroidal anti inflammatory drug (NSAID), the only 1 naphthaleneacetic acid derivative. It is a nonacidic NSAID that is rapidly metabolized in the liver to a major active metabolite, 6 methoxy 2 naphthyl acetic acid. As found with previous NSAIDs, nabumetone's active metabolite inhibits the cyclooxygenase enzyme and preferentially blocks COX 2 activity (which is indirectly responsible for the production of inflammation and pain